New Key Statistics Module, Z-Score and F-Score
NAS:LYRA Key Ratios
| Market Cap $ M | 19.88 |
| Enterprise Value $ M | -28.39 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 0.26 |
| Price/Sales | 11.39 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 1.00 |
| EPS (TTM) $ | -1.20 |
| Beneish M-Score | 6.63 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | 0.70 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | 0.40 |
| EV-to-EBITDA | 0.40 |
| PEG | -- |
| Shares Outstanding M | 60.96 |
| Net Margin (%) | -4,099.82 |
| Operating Margin % | -4,270.18 |
| Pre-tax Margin (%) | -4,096.31 |
| Quick Ratio | 4.78 |
| Current Ratio | 4.78 |
| ROA % (ttm) | -55.17 |
| ROE % (ttm) | -82.82 |
| ROIC % (ttm) | -246.10 |
| Dividend Yield % | -- |
| Altman Z-Score | -4.10 |
LYRA Number of Guru Trades
LYRA Volume of Guru Trades
Gurus Latest Trades with NAS:LYRA
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:LYRA is held by these investors
Total 1
Lyra Therapeutics Inc Insider Transactions
No Available Data
News about NAS:LYRA
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers